CMS advised Bruker on the acquisition of Prolab Instruments
Bruker, a NASDAQ-listed technology company in the analytical instrumentation sector, acquires Prolab.
Prolab, founded in 1988 and headquartered in Reinach, specialises in high-precision low-flow liquid chromatography technology. In this context, the company focuses primarily on micro- and nano-UHPLC pump technology. The zirconium pump developed by Prolab is already a component of Bruker's high-performance mass spectrometry systems.
The acquisition of Prolab provides Bruker with the opportunity to accelerate product innovation. In addition, Prolab's injection technology on the Zirconium Qube Autosampler enables high-precision injections with the smallest sample volumes and minimal sample losses, as well as faster cycle times. Therefore, the acquisition of Prolab ideally complements Bruker's high-performance mass spectrometry systems.
A team from CMS Switzerland, led by Stefan Brunnschweiler, advised Bruker on all legal matters of the transaction.
CMS Switzerland
- Stefan Brunnschweiler, Partner, Corporate / M&A
- Pascal Stocker, Associate, Corporate / M&A
- Dr Simone Brauchbar Birkhäuser, Counsel, IP / IT
- Alexandra Stocker, Associate, Corporate
- Dr Marjolaine Jakob, Partner, Commercial
CMS Germany
- Dr Hendrik Hirsch, Partner, Corporate / M&A
- Dr Berrit Roth-Mingram, Senior Associate, Corporate / M&A
- Dr Thomas Hirse, Partner, IP
- Kai Neuhaus, Partner, Competition
